[Translated article] Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

[Translated article] Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis

Published:2022-07 Issue:7 Volume:113 Page:T674-T684
ISSN:0001-7310
Container-title:Actas Dermo-Sifiliográficas
language:en
Short-container-title:Actas Dermo-Sifiliográficas

Author:

Serra-Baldrich E.,Santamaria-Babí L.F.,Francisco Silvestre J.

Publisher

Elsevier BV

Subject

Dermatology,Histology,Pathology and Forensic Medicine

Reference42 articles.

1. Atopic dermatitis;Langan;Lancet (London, England),2020

2. Clinical practice guidelines for the management of atopic dermatitis 2016;Saeki;J Dermatol,2016

3. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children;Wollenberg;J Eur Acad Dermatol Venereol,2020

4. Clinical characteristics of patients with prurigo nodularis: a descriptive study;Reverte;Ann Dermatol Venereol,2020

5. European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo;Pereira;J Eur Acad Dermatol Venereol,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atopik Dermatit Güncel Patofizyolojisi;Journal of Anatolian Medical Research;2024-04-15

2. A critical evaluation of nemolizumab for prurigo nodularis;Expert Review of Clinical Immunology;2024-01-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP